Company Search:
Advanced Search
Sponsored Links
US Stem Cell Inc Company Snapshot
US Stem Cell Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares US Stem Cell Inc with three other companies in this sector in the United States: Merus NV (2016 sales of $3.00 million of which 100% was Pharmaceutical), DarioHealth Corp ($2.80 million of which 100% was Medical Devices), and Miragen Therapeutics Inc ($3.34 million ).

Sales Analysis. US Stem Cell Inc reported sales of $3.08 million for the year ending December of 2016. This represents an increase of 40.7% versus 2015, when the company's sales were $2.19 million. Sales at US Stem Cell Inc have increased during each of the previous five years (and since 2011, sales have increased a total of 17,544%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
US Stem Cell Inc
  Stock Performance Chart for US Stem Cell Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): .04
(Figures in U.S. Dollars)
1 Week 33.3%   13 Weeks 33.3%  
4 Weeks 21.2%   52 Weeks 900.0%  
US Stem Cell Inc Key Data:
  Ticker: USRM Country: United States
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 3,083,261
(Year Ending Jan 2017).
Employees: 3
  Currency: U.S. Dollars Market Cap: 15,016,532
  Fiscal Yr Ends: December Shares Outstanding: 341,284,817
  Share Type: COMMON Closely Held Shares: 13,540,667
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.